AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
![]() How they continue to withhold valuable information regarding PECO technology and its effectiveness from their readers is appalling. Additionally, Molekule’s devices meet the applicable performance criteria in the FDA’s recent guidance for use in helping reduce the risk of exposure to SARS-CoV-2 in healthcare settings during the pandemic, yet this is a story they refuse to tell their readers. ![]() Food and Drug Administration on our technology for Class II medical device clearance of our Air Pro RX device, and have even flown to New York to meet with them in person to discuss our technology. We have contacted Wirecutter multiple times, provided them accurate information on the company, offered unlimited lab space to test the technology properly, gave them the same testing detail we provided the U.S. You can read more about their aggressive behavior here, here, here, and here for example. They have grossly misrepresented the intent and the conclusion of the NARB ruling, which was initiated by Dyson in the spring of 2019. Wirecutter continues to create a narrative that does not exist. Updated as a response to Wirecutter’s Jarticle.
0 Comments
Read More
Leave a Reply. |